ACHIEVE Trademark

Trademark Overview


On Monday, April 22, 2002, a trademark application was filed for ACHIEVE with the United States Patent and Trademark Office. The USPTO has given the ACHIEVE trademark a serial number of 76398719. The federal status of this trademark filing is ABANDONED - EXPRESS as of Monday, February 10, 2003. This trademark is owned by Advanced Cardiovascular Systems, Inc.. The ACHIEVE trademark is filed in the Medical Instrument Products category with the following description:

drug eluting stent
achieve

General Information


Serial Number76398719
Word MarkACHIEVE
Filing DateMonday, April 22, 2002
Status601 - ABANDONED - EXPRESS
Status DateMonday, February 10, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 29, 2002

Trademark Statements


Goods and Servicesdrug eluting stent

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code8 - Abandoned
Class Status DateWednesday, August 6, 2003
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAdvanced Cardiovascular Systems, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSanta Clara, CA 95054

Party NameAdvanced Cardiovascular Systems, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSanta Clara, CA 95054

Trademark Events


Event DateEvent Description
Monday, February 10, 2003ABANDONMENT - EXPRESS MAILED
Thursday, February 13, 2003PAPER RECEIVED
Tuesday, January 21, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 29, 2002PUBLISHED FOR OPPOSITION
Wednesday, October 9, 2002NOTICE OF PUBLICATION
Tuesday, August 20, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 14, 2002ASSIGNED TO EXAMINER

Related Keywords


achieve stent eluting drug